|
Volumn 36, Issue 4, 2012, Pages 483-484
|
Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia
|
Author keywords
BRAF; Chronic lymphocytic leukaemia; Prolymphocytic leukaemia; Targeted therapy; V600E
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUDARABINE;
PREDNISOLONE;
RITUXIMAB;
VINCRISTINE SULFATE;
ARTICLE;
BRAF GENE;
CHRONIC LYMPHATIC LEUKEMIA;
COHORT ANALYSIS;
CONTROLLED STUDY;
GENE;
GENE AMPLIFICATION;
GENETIC ASSOCIATION;
GENOME ANALYSIS;
HUMAN;
LEUKEMOGENESIS;
LYMPHOCYTOMA;
MAJOR CLINICAL STUDY;
MOLECULAR PATHOLOGY;
MULTIPLE CYCLE TREATMENT;
MUTATION RATE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROLYMPHOCYTIC LEUKEMIA;
SIGNAL TRANSDUCTION;
BASE SEQUENCE;
BLOTTING, WESTERN;
GENOTYPE;
HUMANS;
INCIDENCE;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
LEUKEMIA, PROLYMPHOCYTIC;
MALE;
MIDDLE AGED;
MUTATION;
POLYMERASE CHAIN REACTION;
PROTO-ONCOGENE PROTEINS B-RAF;
|
EID: 84857236614
PISSN: 01452126
EISSN: 18735835
Source Type: Journal
DOI: 10.1016/j.leukres.2011.12.015 Document Type: Article |
Times cited : (28)
|
References (8)
|